Publications by authors named "Per Haamann"

Claim this Profile
R
Reply: Is automated screening for DR indeed not yet ready as stated by Grauslund et al?
Jakob Grauslund, Nis Andersen, Jens Andresen, Per Flesner, Per Haamann

Acta Ophthalmol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based Danish guidelines for screening of diabetic retinopathy.
Jakob Grauslund, Nis Andersen, Jens Andresen, Per Flesner, Per Haamann

Acta Ophthalmol· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The grey fovea sign of macular oedema or subfoveal fluid on non-stereoscopic fundus photographs.
Pascal W Hasler, Wael Soliman, Birgit Sander, Per Haamann, Michael Larsen

Acta Ophthalmol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Central serous chorioretinopathy].
Sara Brandi Bloch, Mette-Marie Orebo Hansen, Per Haamann, Michael Larsen

Ugeskr Laeger· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New treatment of age-related macular degeneration. The Danish Society of Ophthalmology].
Sara Brandi Bloch, Michael Larsen, Per Haamann, Morten La Cour,

Ugeskr Laeger· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exudation, response to photocoagulation and spontaneous remission in a case of bilateral racemose haemangioma.
Wael Soliman, Per Haamann, Michael Larsen

Acta Ophthalmol Scand· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Treatment of neovascular age-related macular degeneration with intravitreal vascular endothelial growth factor inhibitor--secondary publication].
Michael Larsen, Birgit Sander, Jørgen Ebbe Villumsen, Per H Haamann, Morten la Cour

Ugeskr Laeger· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Intravitreal triamcinolone therapy. New therapeutic alternative for patients with vision-threatening eye diseases].
Torben Lykke S Klitgaard, Per H Haamann, Jørgen E Villumsen, Michael Larsen

Ugeskr Laeger· April 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravitreal triamcinolone for macular oedema: efficacy in relation to aetiology.
Torben Lykke Sørensen, Per Haamann, Jørgen Villumsen, Michael Larsen

Acta Ophthalmol Scand· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis